SUBSCRIPTION AGREEMENTSubscription Agreement • May 14th, 2008 • VioQuest Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2008 Company Industry JurisdictionTHIS SUBSCRIPTION AGREEMENT (this “Agreement”) made as of the date set forth on the signature page hereof between VioQuest Pharmaceuticals, Inc., a Delaware corporation having a place of business at 180 Mount Airy Road, Suite 102, Basking Ridge, New Jersey 07920 (the “Company”), and the undersigned (the “Subscriber”).
ContractWarrant Agreement • May 14th, 2008 • VioQuest Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2008 Company Industry JurisdictionTHIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THIS WARRANT AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE PLEDGED, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR DELIVERY OF AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH THE ACT OR UNLESS SOLD IN FULL COMPLIANCE WITH RULE 144 UNDER THE ACT.
FIRST AMENDMENT TO SENIOR CONVERTIBLE PROMISSORY NOTESenior Convertible Promissory Note • May 14th, 2008 • VioQuest Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMay 14th, 2008 Company IndustryTHIS FIRST AMENDMENT TO SENIOR CONVERTIBLE PROMISSORY NOTE (“Amendment”) is entered into as of March __, 2008, by and between VIOQUEST PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and the undersigned, constituting the holders of not less than a majority of the then outstanding principal amount of those certain Senior Convertible Promissory Notes (as amended, the “Notes”), issued on June 29, 2007 and July 3, 2007, on behalf of all of the holders of the Notes or their assigns (“Holders”), to amend, as set forth herein, the terms of all of the outstanding Notes.